Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00192218 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program
A Phase 4 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 4
- Development phase
- 3,022
- Enrollment target
NCT00192218 is a Phase 4 study that has completed, run by MedImmune. The registered enrollment target is 3,022 participants.
The verdict
NCT00192218, a Phase 4 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 3,022 participants
- Enrollment target
Study Summary
To measure the effectiveness of influenza vaccination in school children by comparing, between target(i.e., children are offered FluMist) and control (i.e., children are not offered FluMist) school families.
Interventions
- BIOLOGICAL FluMist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,022 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00192218
The ClinicalTrials.gov registry entry for NCT00192218 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 3,022 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FluMist is the first listed.
NCT00192218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00192218 about?
NCT00192218 is a clinical study titled "Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program". To measure the effectiveness of influenza vaccination in school children by comparing, between target(i.e., children are offered FluMist) and control (i.e., children are not offered FluMist) school families.
What is the current status of trial NCT00192218?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 3,022 participants. The study started on 2004-10. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00192218?
The interventions under investigation include: FluMist (BIOLOGICAL).
Who is sponsoring clinical trial NCT00192218?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.